Takeda Pharmaceutical Co Ltd
10% owner at PHAT; 10% owner at DAWN; 10% owner at Translate Bio, Inc.
- Sold, on record
- $206M
- Dollars the filings state
- Form 4 sales
- 25
- Latest Jan 24, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- PHATPhathom Pharmaceuticals, Inc.10% owner
- DAWNDay One Biopharmaceuticals, Inc.10% owner
- Translate Bio, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Translate Bio, Inc.6.9M shares
- PHAT4.9M shares
- DAWN297,273 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PHATPlan not statedJun 24, 2021 2021
Sold 11,048 shares at $35.14 ($388k)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 1.2% of holdings ($32.2M position)906,741 shares left1.3x usual sizeFiling
- 2 Form 4 sale PHATPlan not statedJun 28, 2021 +4 days
Sold 24,501 shares at $35.49 ($869k)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 2.7% of holdings ($32.2M position)882,240 shares left2.7x usual sizeFiling
- 3 Form 4 sale PHATPlan not statedJul 2, 2021 +4 days
Sold 8,326 shares at $35.16 ($293k)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 0.9% of holdings ($31M position)873,914 shares left0.9x usual sizeFiling
- 4 Form 4 sale PHATPlan not statedJul 7, 2021 +5 days
Sold 2,609 shares at $35.05 ($91k)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 0.3% of holdings ($30.6M position)871,305 shares left0.3x usual sizeFiling
- 5 Form 4 sale PHATUnusualNov 4, 2021 +120 days
Sold 1M shares at $20.85 ($20.9M)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 90.9% of holdings ($22.9M position)100,000 shares left114.9x usual sizeFiling
- 6 Form 4 sale DAWNPlan not statedDec 8, 2021 +34 days
Sold 297,273 shares at $18.49 ($5.5M)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 4.6% of holdings ($119M position)6.1M shares leftFirst sale on recordFiling
- 7 Form 4 sale PHATPlan not statedMar 14, 2022 +96 days
Sold 18 shares at $19.00 ($342)
Takeda Pharmaceutical Co Ltd, 10% owner
Sold 0% of holdings ($142M position)7.5M shares left0x usual sizeFiling
- 8 Form 4 sale PHATUnusualJan 24, 2024 +681 days
Sold 3.7M shares at $8.10 ($30M)
Takeda Pharmaceutical Co Ltd, 10% owner
No 10b5-1 planSold 49.7% of holdings ($60.4M position)3.8M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2024 | Jan 25, 2024 | PHAT | 10% owner | Form 4 sale | 3.7M | $30M | 49.7% | Unusual | SEC |
| Mar 14, 2022 | Mar 16, 2022 | PHAT | 10% owner | Form 4 sale | 18 | $342 | 0.0% | Plan not stated | SEC |
| Dec 8, 2021 | Dec 9, 2021 | DAWN | 10% owner | Form 4 sale | 297,273 | $5.5M | 4.6% | Plan not stated | SEC |
| Nov 4, 2021 | Nov 8, 2021 | PHAT | 10% owner | Form 4 sale | 1M | $20.9M | 90.9% | Unusual | SEC |
| Jul 7, 2021 | Jul 9, 2021 | PHAT | 10% owner | Form 4 sale | 2,609 | $91k | 0.3% | Plan not stated | SEC |
| Jul 2, 2021 | Jul 6, 2021 | PHAT | 10% owner | Form 4 sale | 8,326 | $293k | 0.9% | Plan not stated | SEC |
| Jun 28, 2021 | Jun 29, 2021 | PHAT | 10% owner | Form 4 sale | 24,501 | $869k | 2.7% | Plan not stated | SEC |
| Jun 24, 2021 | Jun 25, 2021 | PHAT | 10% owner | Form 4 sale | 11,048 | $388k | 1.2% | Plan not stated | SEC |
| Jun 22, 2021 | Jun 23, 2021 | PHAT | 10% owner | Form 4 sale | 9,394 | $332k | 1.0% | Plan not stated | SEC |
| Jun 18, 2021 | Jun 21, 2021 | PHAT | 10% owner | Form 4 sale | 8,703 | $306k | 0.9% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 16, 2021 | PHAT | 10% owner | Form 4 sale | 2,826 | $99k | 0.3% | Plan not stated | SEC |
| Jun 10, 2021 | Jun 11, 2021 | PHAT | 10% owner | Form 4 sale | 3,293 | $116k | 0.3% | Plan not stated | SEC |
| Jun 8, 2021 | Jun 9, 2021 | PHAT | 10% owner | Form 4 sale | 2,364 | $83k | 0.3% | Plan not stated | SEC |
| Jun 2, 2021 | Jun 4, 2021 | PHAT | 10% owner | Form 4 sale | 4,300 | $151k | 0.5% | Plan not stated | SEC |
| Jun 1, 2021 | Jun 2, 2021 | PHAT | 10% owner | Form 4 sale | 20,116 | $723k | 2.1% | Plan not stated | SEC |
| May 27, 2021 | May 28, 2021 | PHAT | 10% owner | Form 4 sale | 20,811 | $767k | 2.1% | Plan not stated | SEC |
| May 25, 2021 | May 26, 2021 | PHAT | 10% owner | Form 4 sale | 21,541 | $774k | 2.1% | Plan not stated | SEC |
| May 21, 2021 | May 24, 2021 | PHAT | 10% owner | Form 4 sale | 18,746 | $665k | 1.8% | Plan not stated | SEC |
| May 14, 2021 | May 18, 2021 | PHAT | 10% owner | Form 4 sale | 100 | $4k | 0.0% | Plan not stated | SEC |
| May 13, 2021 | May 14, 2021 | PHAT | 10% owner | Form 4 sale | 11,876 | $421k | 1.1% | Plan not stated | SEC |
| May 7, 2021 | May 11, 2021 | PHAT | 10% owner | Form 4 sale | 1,011 | $35k | 0.1% | Plan not stated | SEC |
| May 6, 2021 | May 7, 2021 | PHAT | 10% owner | Form 4 sale | 7,138 | $251k | 0.7% | Plan not stated | SEC |
| May 4, 2021 | May 5, 2021 | PHAT | 10% owner | Form 4 sale | 33,992 | $1.3M | 3.1% | Plan not stated | SEC |
| Jun 30, 2020 | Jun 30, 2020 | Translate Bio, Inc. | 10% owner | Form 4 sale | 6.8M | $141M | 100.0% | Unusual | SEC |
| Jun 3, 2020 | Jun 5, 2020 | Translate Bio, Inc. | 10% owner | Form 4 sale | 40,086 | $792k | 0.6% | Plan not stated | SEC |